NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations…
Up to 16 million adults in the US are living with a neurological disease, the leading cause of physical and…
When we bring together people from different backgrounds, the possibilities for invention are endlessNORTHAMPTON, MA / ACCESSWIRE / February 13,…
BOSTON, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the presentation…
—Company receives FDA IND clearance for the development of enobosarm in combination with GLP-1 drugs for potentially higher quality weight…
TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Eligible First Nations communities and individuals have until March 7, 2024, to submit…
MIAMI, FL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Magdalena aiming to submit Investigational New Drug application in 2024 to the FDA for this next-generation psychoactive prescription drug candidate…
BioMedical Waste Solutions Encourages Healthcare Facilities, Professionals and Individuals Utilizing Needles to Read Its Comprehensive Guide for Assistance With the…
WÜRZBURG, Germany and CAMBRIDGE, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) -- DAHW German Leprosy and Tuberculosis Relief Association and BelleTorus…